Lack of coordination between partners: investigation of Physician-Preferred and Patient-Preferred (4P) basal insulin titration algorithms in the real world

References

• InzucchiSEBergenstalRMBuseJBManagement of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of DiabetesDiabetes Care201538114014925538310
   PubMed Web of Science ®Google Scholar
• GarberAJAbrahamsonMJBarzilayJIConsensus statement by the american association of clinical endocrinologists and american college of endocrinology on the comprehensive type 2 diabetes management algorithm – 2016 executive summaryEndocr Pract20162218411326731084
   PubMed Web of Science ®Google Scholar
• GarberAJThe importance of titrating starting insulin regimens in patients with type 2 diabetesDiabetes Obes Metab200911Suppl 51013
   Web of Science ®Google Scholar
• TsaiSTPathanFJiLFirst insulinization with basal insulin in patients with type 2 diabetes in a real-world setting in AsiaJ Diabetes20113320821621631903
   PubMed Web of Science ®Google Scholar
• JiLZhangPZhuDObservational Registry of Basal Insulin Treatment (ORBIT) in patients with type 2 diabetes uncontrolled with oral antihyperglycaemic drugs: real-life use of basal insulin in ChinaDiabetes Obes Metab201719682283028105735
   PubMed Web of Science ®Google Scholar
• Yki-JärvinenHRyysyLKauppilaMEffect of obesity on the response to insulin therapy in noninsulin-dependent diabetes mellitusJ Clin Endocrinol Metab19978212403740439398709
   PubMed Web of Science ®Google Scholar
• RiddleMCRosenstockJGerichJInsulin Glargine 4002 Study InvestigatorsThe treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patientsDiabetes Care200326113080308614578243
   PubMed Web of Science ®Google Scholar
• DaviesMStormsFShutlerSBianchi-BiscayMGomisRATLANTUS Study GroupImprovement of glycemic control in subjects with poorly controlled type 2 diabetes: comparison of two treatment algorithms using insulin glargineDiabetes Care20052861282128815920040
   PubMed Web of Science ®Google Scholar
• GersteinHCYaleJFHarrisSBIssaMStewartJADempseyEA randomized trial of adding insulin glargine vs. avoidance of insulin in people with Type 2 diabetes on either no oral glucose-lowering agents or submaximal doses of metformin and/or sulphonylureas. The Canadian INSIGHT (Implementing New Strategies with Insulin Glargine for Hyperglycaemia Treatment) studyDiabet Med200623773674216842477
   PubMed Web of Science ®Google Scholar
• MeneghiniLKoenenCWengWSelamJLThe usage of a simplified self-titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes – results of the randomized, controlled PREDICTIVE 303 studyDiabetes Obes Metab20079690291317924873
   PubMed Web of Science ®Google Scholar
• GargSKAdmaneKFreemantleNPatient-led versus physician-led titration of insulin glargine in patients with uncontrolled type 2 diabetes: a randomized multinational ATLAS studyEndocr Pract201521214315725297660
   PubMed Web of Science ®Google Scholar
• InzucchiSEBergenstalRMBuseJBAmerican Diabetes Association (ADA)European Association for the Study of Diabetes (EASD)Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Diabetes Care20123561364137922517736
   PubMed Web of Science ®Google Scholar
• BlondeLMerilainenMKarweVRaskinPTITRATE Study GroupPatient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets – the TITRATE studyDiabetes Obes Metab200911662363119515182
   PubMed Web of Science ®Google Scholar
• RosenstockJDaviesMHomePDLarsenJKoenenCSchernthanerGA randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetesDiabetologia200851340841618204830
   PubMed Web of Science ®Google Scholar
• KennedyLHermanWHStrangePHarrisAGOAL AIC TeamImpact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trialDiabetes Care20062911816373887
   PubMed Web of Science ®Google Scholar
• FritscheASchweitzerMAHaringHU4001 Study GroupGlimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes. A randomized, controlled trialAnn Intern Med20031381295295912809451
   PubMed Web of Science ®Google Scholar
• RaskinPAllenEHollanderPINITIATE Study GroupInitiating insulin therapy in type 2 diabetes: a comparison of biphasic and basal insulin analogsDiabetes Care200528226026515677776
   PubMed Web of Science ®Google Scholar
• VaagALundSSInsulin initiation in patients with type 2 diabetes mellitus: treatment guidelines, clinical evidence and patterns of use of basal vs premixed insulin analoguesEur J Endocrinol2012166215917021930715
   PubMed Web of Science ®Google Scholar
• PeyrotMBarnettAHMeneghiniLFSchumm-DraegerPMInsulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy studyDiabet Med201229568268922313123
   PubMed Web of Science ®Google Scholar
• DaileyGAurandLStewartJAmeerBZhouRComparison of three algorithms for initiation and titration of insulin glargine in insulin-naive patients with type 2 diabetes mellitusJ Diabetes20146217618323931125
   PubMed Web of Science ®Google Scholar
• KhuntiKDaviesMJKalraSSelf-titration of insulin in the management of people with type 2 diabetes: a practical solution to improve management in primary careDiabetes Obes Metab201315869070023253563
   PubMed Web of Science ®Google Scholar
• PfutznerAStratmannBFunkeKReal-world data collection regarding titration algorithms for insulin glargine in patients with type 2 diabetes mellitusJ Diabetes Sci Technol20161051122112927325389
   PubMedGoogle Scholar
• Yki-JarvinenHCombination therapies with insulin in type 2 diabetesDiabetes Care200124475876711315844
   PubMed Web of Science ®Google Scholar
• Yki-JarvinenHKauppinen-MakelinRTiikkainenMInsulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET studyDiabetologia200649344245116456680
   PubMed Web of Science ®Google Scholar
• Yki-JarvinenHJuurinenLAlvarssonMInitiate Insulin by Aggressive Titration and Education (INITIATE): a randomized study to compare initiation of insulin combination therapy in type 2 diabetic patients individually and in groupsDiabetes Care20073061364136917384341
   PubMed Web of Science ®Google Scholar
• HeineRJVan GaalLFJohnsDMihmMJWidelMHBrodowsRGExenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trialAnn Intern Med2005143855956916230722
   PubMed Web of Science ®Google Scholar
• JankaHUPleweGRiddleMCKliebe-FrischCSchweitzerMAYki-JarvinenHComparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetesDiabetes Care200528225425915677775
   PubMed Web of Science ®Google Scholar
• EliaschewitzFGCalvoCValbuenaHHOE 901/4013 LA Study GroupTherapy in type 2 diabetes: insulin glargine vs NPH insulin both in combination with glimepirideArch Med Res200637449550116715577
   PubMed Web of Science ®Google Scholar
• StrangePTreat-to-target insulin titration algorithms when initiating long or intermediate acting insulin in type 2 diabetesJ Diabetes Sci Technol20071454054819885117
   PubMedGoogle Scholar
• ZinmanBFulcherGRaoPVInsulin degludec, an ultra-long-acting basal insulin, once a day or three times a week versus insulin glargine once a day in patients with type 2 diabetes: a 16-week, randomised, open-label, phase 2 trialLancet2011377976992493121396703
   PubMed Web of Science ®Google Scholar
• SchreiberSAHaakTInsulin glargine benefits patients with type 2 diabetes inadequately controlled on oral antidiabetic treatment: an observational study of everyday practice in 12,216 patientsDiabetes Obes Metab200791313817199716
   PubMed Web of Science ®Google Scholar
• Yki-JarvinenHRyysyLNikkilaKTulokasTVanamoRHeikkilaMComparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trialAnn Intern Med1999130538939610068412
   PubMed Web of Science ®Google Scholar
• KodamaKTojjarDYamadaSTodaKPatelCJButteAJEthnic differences in the relationship between insulin sensitivity and insulin response: a systematic review and meta-analysisDiabetes Care20133661789179623704681
   PubMed Web of Science ®Google Scholar